Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
AnaptysBio Inc (GB:0HFQ)
LSE:0HFQ
AnaptysBio (0HFQ) Stock Price & Analysis
0 Followers
0HFQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$21.26 - $29.76
Previous Close$24.36
Volume0.00
Average Volume (3M)17.00
Market Cap
$591.02M
Enterprise Value$169.23M
Total Cash (Recent Filing)$441.24M
Total Debt (Recent Filing)$19.45M
Price to Earnings (P/E)N/A
Beta-0.18
Next Earnings
May 09, 2023EPS Estimate
-$1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,931,028
10 Day Avg. Volume0
30 Day Avg. Volume17
Standard Deviation0.24
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.28
Price to Sales (P/S)68.51
Price to Cash Flow (P/CF)48.40
P/FCF Ratio-8.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue16.45
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.61
Forecast
1Y Price Target
$29.50Price Target Upside21.10% Upside
Rating ConsensusHold
Number of Analyst Covering3
AnaptysBio News
0HFQ FAQ
What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest stock price was $21.26 and its highest was $29.75 in the past 12 months.
What is AnaptysBio Inc’s market cap?
Currently, no data Available
When is AnaptysBio Inc’s upcoming earnings report date?
AnaptysBio Inc’s upcoming earnings report date is May 09, 2023 which is in 38 days.
How were AnaptysBio Inc’s earnings last quarter?
AnaptysBio Inc released its earnings results on Mar 01, 2023. The company reported -$0.93 earnings per share for the quarter, beating the consensus estimate of -$0.957 by $0.027.
Is AnaptysBio Inc overvalued?
According to Wall Street analysts AnaptysBio Inc’s price is currently Undervalued.
Does AnaptysBio Inc pay dividends?
AnaptysBio Inc does not currently pay dividends.
What is AnaptysBio Inc’s EPS estimate?
AnaptysBio Inc’s EPS estimate is -$1.02.
How many shares outstanding does AnaptysBio Inc have?
Currently, no data Available
What happened to AnaptysBio Inc’s price movement after its last earnings report?
AnaptysBio Inc reported an EPS of -$0.93 in its last earnings report, beating expectations of -$0.957. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AnaptysBio Inc?
Among the largest hedge funds holding AnaptysBio Inc’s share is Deerfield Management Company, LP. It holds AnaptysBio Inc’s shares valued at 36M.
---
AnaptysBio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$29.50 (21.10% Upside)
$29.50 (21.10% Upside)
Blogger Sentiment
Bullish
GB:0HFQ Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.49%
12-Months-Change
Fundamentals
Return on Equity
-41.62%
Trailing 12-Months
Asset Growth
-5.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AnaptysBio Inc
AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
---
Design Therapeutics
―
Seres Therapeutics
―
IDEAYA Biosciences
―
Gossamer Bio
―
Agenus
―
---